Minimally Invasive Gynecologic Surgery | NYU Langone Health
At NYU Langone, surgeons use minimally invasive techniques to perform gynecologic surgery, with faster recovery, less pain, and shorter hospital stays.
Minimally Invasive Gynecologic Surgery Doctors | NYU Langone Health
Find a doctor at the Minimally Invasive Gynecologic Surgery at NYU Langone.
Minimally Invasive Procedures for Aortoiliac Occlusive Disease | NYU Langone Health
NYU Langone doctors perform procedures that improve blood flow by opening up blockages in people with aortoiliac occlusive disease.
Minimally Invasive Procedures for Chronic Venous Insufficiency | NYU Langone Health
NYU Langone doctors use minimally invasive techniques to manage chronic venous insufficiency.
Minimally Invasive Procedures for Deep Vein Thrombosis | NYU Langone Health
NYU Langone specialists may recommend clot removal and vein filters to manage deep vein thrombosis, or DVT, often together with medication.
Minimally Invasive Procedures for Dry Eye Disease | NYU Langone Health
NYU Langone doctors may recommend minimally invasive procedures, including punctal plugs and cauterization, to treat dry eye disease.
Minimally Invasive Procedures for Varicose Veins | NYU Langone Health
NYU Langone doctors use minimally invasive procedures to eliminate varicose veins.
Minimally Invasive Repair for Mitral Valve Disease | NYU Langone Health
NYU Langone cardiothoracic surgeons repair damaged mitral valves, often using minimally invasive techniques.
Minimally Invasive Treatment for Arrhythmias in Children | NYU Langone Health
Specialists at Hassenfeld Children’s Hospital at NYU Langone use minimally invasive procedures to treat some types of childhood arrhythmias.
Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
The purpose of this research study is to see if mirikizumab is effective in treating pouch-related disorders. Participants with an established diagnosis of chronic pouchitis or Crohn’s-like disease of the pouch will be offered the option of enrolling in an open-label trial with mirikizumab. The study aims to assess the clinical response to treatment with mirikizumab and endoscopic healing among patients with chronic inflammatory conditions of the pouch